Health Care: Drugs

Infinity Pharmaceuticals Inc (INFI: NASDAQ)

$3.39 n/a | n/a%
03/27/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.39
52 Week High 6.63
52 Week Low 0.84
Avg. Daily Vol. (Mil) 1.22
Beta (3 year) 2.68
Share Related Items
Mkt Cap (Mil) 170.94
Shares Out (Mil) 50.43
Float (Mil) 33.02
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.90
Current Ratio 4.30
LT Debt/ Equity 0.23
Total Debt / Equity 0.24
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.13
Price/Book 2.07
Price/Cash Flow -6.40
Per Share Data
Earnings -0.61
Sales 0.37
Book Value 1.64
Cash Flow -0.53
Business Summary
Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its product candidate is duvelisib, also known as IPI-145, an oral inhibitor.
General Information
784 Memorial Drive
Cambridge, MA 02139
Industry : Drugs
Sector: Health Care
Employees: 23
CEO: Ms. Adelene Q. Perkins
Short Interest
Current Month (Mil) 3.54
Previous Month (Mil) 3.38
Short Interest Ratio (Days) 3.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -24.00
Return on Investments -29.60
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with INFI

Latest INFI Headlines from TheStreet

More Financial News for INFI

Press Releases for INFI

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter